DK1254209T3 - Sammensætning omfattende hydroxycitronsyre og garcinol til vægttab - Google Patents

Sammensætning omfattende hydroxycitronsyre og garcinol til vægttab

Info

Publication number: DK1254209T3
Authority: DK; Denmark
Prior art keywords: garcinol; anthocyanin; composition; hca; reduction
Prior art date: 2000-08-17

Application number

DK01977759T

Other languages

English (en)

Inventor

Muhammed Majeed

Vladimir Badmaev

Original Assignee

Sabinsa Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-17

Filing date

2001-08-17

Publication date

2006-07-24

2001-08-17 Application filed by Sabinsa Corp filed Critical Sabinsa Corp

2006-07-24 Application granted granted Critical

2006-07-24 Publication of DK1254209T3 publication Critical patent/DK1254209T3/da

Links

DTTONLKLWRTCAB-UDFURZHRSA-N (1s,3e,5r,7r)-3-[(3,4-dihydroxyphenyl)-hydroxymethylidene]-6,6-dimethyl-5,7-bis(3-methylbut-2-enyl)-1-[(2s)-5-methyl-2-prop-1-en-2-ylhex-4-enyl]bicyclo[3.3.1]nonane-2,4,9-trione Chemical compound O=C([C@@]1(C(C)(C)[C@H](CC=C(C)C)C[C@](C2=O)(C1=O)C[C@H](CC=C(C)C)C(C)=C)CC=C(C)C)\C2=C(\O)C1=CC=C(O)C(O)=C1 DTTONLKLWRTCAB-UDFURZHRSA-N 0.000 title abstract 6
QDKLRKZQSOQWJQ-JGWHSXGBSA-N Garcinol Natural products O=C([C@@]1(C(C)(C)[C@@H](CC=C(C)C)C[C@](C=2O)(C1=O)C[C@H](CC=C(C)C)C(C)=C)CC=C(C)C)C=2C(=O)C1=CC=C(O)C(O)=C1 QDKLRKZQSOQWJQ-JGWHSXGBSA-N 0.000 title abstract 6
ZMJBYMUCKBYSCP-UHFFFAOYSA-N Hydroxycitric acid Chemical compound OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 title abstract 6
LMFLOMBYUXRHIL-UHFFFAOYSA-N garcifuran-A Natural products COC1=C(O)C(OC)=CC(C=2C(=C3C=COC3=CC=2)O)=C1 LMFLOMBYUXRHIL-UHFFFAOYSA-N 0.000 title abstract 6
GRBCIRZXESZBGJ-UHFFFAOYSA-N guttiferone F Natural products CC(=CCCC(C(=C)C)C12CC(CC=C(C)C)C(C)(C)C(CC=C(C)C)(C(=O)C(=C1O)C(=O)c3ccc(O)c(O)c3)C2=O)C GRBCIRZXESZBGJ-UHFFFAOYSA-N 0.000 title abstract 6
229940089491 hydroxycitric acid Drugs 0.000 title abstract 6
230000004580 weight loss Effects 0.000 title abstract 3
235000010208 anthocyanin Nutrition 0.000 abstract 5
229930002877 anthocyanin Natural products 0.000 abstract 5
239000004410 anthocyanin Substances 0.000 abstract 5
150000004636 anthocyanins Chemical class 0.000 abstract 5
OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
238000002560 therapeutic procedure Methods 0.000 abstract 2
208000016261 weight loss Diseases 0.000 abstract 2
108010036824 Citrate (pro-3S)-lyase Proteins 0.000 abstract 1
SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
241001529936 Murinae Species 0.000 abstract 1
210000000577 adipose tissue Anatomy 0.000 abstract 1
230000003078 antioxidant effect Effects 0.000 abstract 1
230000036528 appetite Effects 0.000 abstract 1
235000019789 appetite Nutrition 0.000 abstract 1
210000000476 body water Anatomy 0.000 abstract 1
230000037396 body weight Effects 0.000 abstract 1
OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Obesity (AREA)
Diabetes (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Lubricants (AREA)

DK01977759T 2000-08-17 2001-08-17 Sammensætning omfattende hydroxycitronsyre og garcinol til vægttab DK1254209T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US22582100P	2000-08-17	2000-08-17

Publications (1)

Publication Number	Publication Date
DK1254209T3 true DK1254209T3 (da)	2006-07-24

Family

ID=22846386

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01977759T DK1254209T3 (da)	2000-08-17	2001-08-17	Sammensætning omfattende hydroxycitronsyre og garcinol til vægttab

Country Status (12)

Country	Link
US (1)	US7063861B2 (da)
EP (1)	EP1254209B1 (da)
JP (2)	JP4205943B2 (da)
AT (1)	ATE320248T1 (da)
AU (1)	AU773081B2 (da)
CA (1)	CA2387548A1 (da)
DE (1)	DE60118019T2 (da)
DK (1)	DK1254209T3 (da)
ES (1)	ES2260293T3 (da)
NZ (1)	NZ518116A (da)
PT (1)	PT1254209E (da)
WO (1)	WO2002014477A2 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4205943B2 (ja) *	2000-08-17	2009-01-07	サビンサコーポレーション	天然および合成ｈｃａのバイオアベイラブルな組成物
US20030187055A1 (en) *	2002-02-25	2003-10-02	Riker Donald K.	Synergistic pharmaceutical combinations for treating obesity
US7507421B2 (en) *	2002-04-30	2009-03-24	Unibar Corporation	Hydroxycitric acid salt composition and method of making
US8394856B2 (en) *	2002-07-02	2013-03-12	Glykon Technologies Group, Llc	(-)-Hydroxycitric acid for controlling inflammation
JP2007502331A (ja) *	2003-05-29	2007-02-08	グリュコンテクノロジーズグループエルエルシー	（−）−ヒドロキシクエン酸を安定して制御送達するための方法および組成物
US7261769B2 (en)	2003-07-03	2007-08-28	Unibar Corporation	Stabilized anthocyanin extract from Garcinia indica
US20050009919A1 (en) *	2003-07-07	2005-01-13	Clouatre Dallas L.	Treating cachexia and excessive catabolism with (-)-hydroxycitric acid
US20080207952A1 (en) *	2003-10-09	2008-08-28	Muhammed Majeed	Novel therapeutic applications of natural poly isoprenylated benzophenone derivatives as drugs/medicaments
US7386111B2 (en) *	2004-02-10	2008-06-10	Vonage Network Inc.	Method and apparatus for placing a long distance call based on a virtual phone number
US8138162B2 (en)	2004-06-04	2012-03-20	Horizon Science Pty Ltd.	Natural sweetener
US8021697B2 (en)	2005-06-03	2011-09-20	Horizon Science Pty. Ltd.	Substances having body mass redistribution properties
CN101553582A (zh)	2006-09-19	2009-10-07	视界科技有限公司	从甘蔗中获得的提取物及其生产方法
US20080095867A1 (en) *	2006-10-19	2008-04-24	Renaissance Herbs, Inc.	Hydroxycitric acid compositions from garcinia cambogia and hibiscus sp., methods of making, and therapeutic uses of same
CA2686419A1 (en) *	2007-05-04	2008-11-13	Nutraceutic Et Business Consulting	Composition having lipolytic activity, production method thereof and use of the composition
JP5117762B2 (ja) *	2007-05-18	2013-01-16	株式会社半導体エネルギー研究所	液晶表示装置
US20090062231A1 (en) *	2007-08-31	2009-03-05	O'mara Ann Marie	Appetite Suppressant Composition and Method of Appetite Suppression
US20100233306A1 (en) *	2009-03-16	2010-09-16	Sevanti Mehta	Methods and compositions for weight loss using garcinia indica fruit puree
KR20130118900A (ko) *	2010-12-30	2013-10-30	무하메드 마제에드	가르시놀의 간 보호적 활성
US8329743B2 (en) *	2011-01-10	2012-12-11	Sami Labs Limited	Compositions and its use in treating obesity or inducing weight loss
EP2672832B1 (en)	2011-02-08	2020-03-25	The Product Makers (Australia) Pty Ltd	Sugar extracts
WO2014032100A1 (en)	2012-08-28	2014-03-06	Phytolin Pty Ltd	Extraction method
US10350259B2 (en)	2013-08-16	2019-07-16	The Product Makers (Australia) Pty Ltd	Sugar cane derived extracts and methods of treatment
US10285961B2 (en)	2014-02-06	2019-05-14	University Of Houston System	Organic acids as agents to dissolve calcium minerals in pathological calcification and uses thereof
KR101781365B1 (ko) *	2016-08-31	2017-09-25	주식회사 코씨드바이오팜	반응표면분석법을 이용하여 가르시니아 캄보지아로부터 하이드록시 시트르산을 고수율로 추출하는 방법
EP3638226A4 (en) *	2017-06-15	2021-04-07	Sami Labs Limited	POTENTIAL OF GARCINOL AGAINST OBESITY
WO2019212929A1 (en) *	2018-04-30	2019-11-07	Muhammed Majeed	Compositions for weight loss
KR102728051B1 (ko) *	2021-11-26	2024-11-11	주식회사 청안오가닉스	초임계 유체를 이용한 가르시니아 캄보지아로부터 하이드록시 시트르산의 추출방법
GB2623571A (en) *	2022-10-21	2024-04-24	Mootral Innovations Ltd	Compositions for reducing methane emission

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1276253B1 (it)	1995-12-15	1997-10-27	Sigma Tau Ind Farmaceuti	Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
WO1997023210A1 (fr) *	1995-12-26	1997-07-03	Suntory Limited	Agent anti-obesite dont le principe actif est la procyanidine
JPH10203968A (ja) *	1997-01-27	1998-08-04	Munekazu Iinuma	抗腫瘍剤
JPH10265397A (ja) *	1997-03-25	1998-10-06	Toyotama Kenko Shokuhin Kk	肥満予防剤
JPH111431A (ja) *	1997-06-10	1999-01-06	Nichiyaku Kk	肥満抑制剤
JPH11139965A (ja) *	1997-11-06	1999-05-25	Kikkoman Corp	抗腫瘍薬
JP2000044468A (ja) *	1998-07-29	2000-02-15	Kikkoman Corp	リパーゼ阻害剤及び抗肥満剤又は高脂血症抑制剤
JP2000072665A (ja) *	1998-08-31	2000-03-07	Kikkoman Corp	ヒアルロニダーゼ阻害剤
AU5802499A (en) *	1998-09-01	2000-03-21	Amway Corporation	Diet composition and method of weight management
FR2790645B1 (fr)	1999-03-12	2001-06-08	Arkopharma Laboratoires	Complement alimentaire et procede de traitement cosmetique a base d' un extrait de raisin riche en polyphenols
JP2000355536A (ja) *	1999-06-10	2000-12-26	Kikkoman Corp	発癌予防薬
FR2804319B1 (fr) *	2000-01-28	2002-10-25	Clarins Lab	Composition cosmetique amincissante comprenant en tant qu'agent actif un extrait de plante contenant de l'anp
JP4205943B2 (ja) *	2000-08-17	2009-01-07	サビンサコーポレーション	天然および合成ｈｃａのバイオアベイラブルな組成物

2001
- 2001-08-17 JP JP2002519605A patent/JP4205943B2/ja not_active Expired - Lifetime
- 2001-08-17 AT AT01977759T patent/ATE320248T1/de active
- 2001-08-17 AU AU96851/01A patent/AU773081B2/en not_active Expired
- 2001-08-17 CA CA002387548A patent/CA2387548A1/en not_active Abandoned
- 2001-08-17 EP EP01977759A patent/EP1254209B1/en not_active Expired - Lifetime
- 2001-08-17 PT PT01977759T patent/PT1254209E/pt unknown
- 2001-08-17 ES ES01977759T patent/ES2260293T3/es not_active Expired - Lifetime
- 2001-08-17 DE DE60118019T patent/DE60118019T2/de not_active Expired - Lifetime
- 2001-08-17 NZ NZ518116A patent/NZ518116A/en not_active IP Right Cessation
- 2001-08-17 DK DK01977759T patent/DK1254209T3/da active
- 2001-08-17 US US09/926,746 patent/US7063861B2/en not_active Expired - Lifetime
- 2001-08-17 WO PCT/US2001/041748 patent/WO2002014477A2/en active IP Right Grant
2008
- 2008-01-30 JP JP2008018756A patent/JP2008110996A/ja active Pending

Also Published As

Publication number	Publication date
JP2004506657A (ja)	2004-03-04
AU9685101A (en)	2002-02-25
ATE320248T1 (de)	2006-04-15
EP1254209B1 (en)	2006-03-15
PT1254209E (pt)	2006-08-31
DE60118019D1 (de)	2006-05-11
JP4205943B2 (ja)	2009-01-07
EP1254209A2 (en)	2002-11-06
US20020187943A1 (en)	2002-12-12
EP1254209A4 (en)	2004-09-08
NZ518116A (en)	2005-06-24
DE60118019T2 (de)	2006-11-02
WO2002014477A3 (en)	2002-08-01
AU773081B2 (en)	2004-05-13
WO2002014477A2 (en)	2002-02-21
ES2260293T3 (es)	2006-11-01
US7063861B2 (en)	2006-06-20
JP2008110996A (ja)	2008-05-15
CA2387548A1 (en)	2002-02-21

Publication	Publication Date	Title
DK1254209T3 (da)	2006-07-24	Sammensætning omfattende hydroxycitronsyre og garcinol til vægttab
DE60209504D1 (de)	2006-04-27	Carbocyclische hydrazino-hemmer von kupferhaltigen aminoxidasen
TW200633695A (en)	2006-10-01	Methods for purifying trans-(-)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinol
ATE506059T1 (de)	2011-05-15	Therapie zur behandlung der überaktiven blase
TW200600092A (en)	2006-01-01	Topical slimming preparation and a cosmetic containing a carnitine derivative
CY1105930T1 (el)	2011-04-06	Χρηση αναστολεων c-kit για θepαπεια ασθενειων φλεγμονωδους εντερου (ibd)
DK0832081T3 (da)	2003-05-26	Bicykliske-aromatiske forbindelser
NZ328874A (en)	1999-06-29	Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders
DE60230961D1 (de)	2009-03-12	Verwendung einer dihydrochalcon-reichen phenolischen Fraktion für eine kosmetische Behandlung
ATE198467T1 (de)	2001-01-15	Diaromatische propynyl- oder dienylverbindungen
BR0008865A (pt)	2002-01-02	Composições contendo fluoreto estanhoso para o tratamento de dentes hipersensìveis
BR0310061A (pt)	2005-03-01	Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
BR0201974A (pt)	2003-04-22	Composição farmacêutica para tratamento de alterações do sono
EA200501549A1 (ru)	2006-04-28	Применение экспрессирующего вектора, кодирующего ингибитор il-18, для лечения и/или профилактики заболевания сердца и способ лечения заболевания сердца
BRPI0418854A (pt)	2007-11-20	composições herbáceas
TW200501973A (en)	2005-01-16	Method of improvement of blood circulation
DE50210605D1 (de)	2007-09-13	Gewürzkrautzubereitung
RU2673075C1 (ru)	2018-11-22	Защитный крем для участков кожи с ограниченным воздухообменом
UA32384A (uk)	2000-12-15	Спосіб лікування пародонтиту
TW200505918A (en)	2005-02-16	Azaquinazoline derivatives